Educational Interventions

Based on the barriers to integration of immunotherapies identified by the sites participating in the quality improvement project, the following webinars were developed to address specific challenges, providing training and tools to support all members of the multidisciplinary team involved in the care of patients treated with immunotherapy for cancer.  

Clinical Advances in Immunotherapy

Ali McBride, PharmD, MS, BCOP, and  Igor Puzanov, MD, MSCI, FACP

Review the latest IO approvals and new indications and hear about IO combination therapies, combination considerations, and how to approach IO doublet therapy for your patient. 
View Webinar

Common Immune-Related Adverse Events (irAEs)

Ali McBride, PharmD, MS, BCOP, and Joanne Riemer, RN, BSN

With expanding approvals and indications for immuno-oncology, the understanding of irAEs continues to evolve. Early recognition and management of irAEs is critical as these side can quickly become serious. This presentation covers effective practices to recognize, grade, evaluate, treat, and follow-up on irAEs. The faculty discuss three irAE case studies and resources on managing immune-related toxicities.
View Webinar

Rare Immune-Related Adverse Events (irAEs)

Matthew Zibelman, MD, and Joanne Riemer, RN, BSN

As experience with new immunotherapies and combination therapies increases, understanding of less commonly occurring irAEs continues to expand. Learn how two academic medical centers are developing institution-level strategies to optimize the management of rare irAEs in patients receiving immunotherapies.
View Webinar 

Challenges with Implementing Immunotherapy

Igor Puzanov, MD, MSCI, FACP, and Matthew Zibelman, MD

Hear an interactive dialogue between these experts on considerations for patient selection when individuals have existing comorbidities,  monitoring and managing irAEs, consistent grading of AEs, care coordination with providers outside the oncology team, and patient education on how to recognize early signs and symptoms of adverse reactions.
View Webinar